Responses
Interventional Cardiology
60 The ardvaarc study (altered rivaroxaban doses, vitamin-K anticoagulation & academic research consortium bleeding): real-world’ outcomes of patients who require anticoagulation following percutaneous coronary intervention (PCI)
Compose a Response to This Article
Other responses
No responses have been published for this article.